The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123271862 12327186 2 F 20131111 20160827 20160503 20160912 EXP PHEH2016US010580 NOVARTIS 62.38 YR F Y 0.00000 20160912 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123271862 12327186 1 PS RECLAST ZOLEDRONIC ACID 1 Unknown U 21817 SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123271862 12327186 1 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
123271862 12327186 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123271862 12327186 Abscess
123271862 12327186 Affective disorder
123271862 12327186 Anxiety
123271862 12327186 Arrhythmia
123271862 12327186 Arterial occlusive disease
123271862 12327186 Arthralgia
123271862 12327186 Bipolar disorder
123271862 12327186 Blood pressure decreased
123271862 12327186 Cellulitis
123271862 12327186 Chills
123271862 12327186 Chronic obstructive pulmonary disease
123271862 12327186 Colitis microscopic
123271862 12327186 Cough
123271862 12327186 Decreased appetite
123271862 12327186 Deep vein thrombosis
123271862 12327186 Deformity
123271862 12327186 Depression
123271862 12327186 Diplopia
123271862 12327186 Dizziness
123271862 12327186 Dysphagia
123271862 12327186 Ear pain
123271862 12327186 Faeces discoloured
123271862 12327186 Fall
123271862 12327186 Fatigue
123271862 12327186 Haemoglobin decreased
123271862 12327186 Headache
123271862 12327186 Hyperlipidaemia
123271862 12327186 Hypertension
123271862 12327186 Hypoaesthesia
123271862 12327186 Hypokalaemia
123271862 12327186 Hypothyroidism
123271862 12327186 Injury
123271862 12327186 Insomnia
123271862 12327186 Intermittent claudication
123271862 12327186 Joint swelling
123271862 12327186 Klebsiella infection
123271862 12327186 Limb injury
123271862 12327186 Lipoma
123271862 12327186 Lymphadenopathy
123271862 12327186 Mouth swelling
123271862 12327186 Musculoskeletal pain
123271862 12327186 Myalgia
123271862 12327186 Neoplasm
123271862 12327186 Nephrolithiasis
123271862 12327186 Neuropathy peripheral
123271862 12327186 Oral mucosal blistering
123271862 12327186 Oral pain
123271862 12327186 Oropharyngeal pain
123271862 12327186 Osteoarthritis
123271862 12327186 Osteomyelitis
123271862 12327186 Osteonecrosis of jaw
123271862 12327186 Pain in extremity
123271862 12327186 Pyrexia
123271862 12327186 Respiratory failure
123271862 12327186 Rhinorrhoea
123271862 12327186 Sarcoidosis
123271862 12327186 Single functional kidney
123271862 12327186 Sinus bradycardia
123271862 12327186 Snoring
123271862 12327186 Stress urinary incontinence
123271862 12327186 Type 2 diabetes mellitus
123271862 12327186 Upper gastrointestinal haemorrhage
123271862 12327186 Upper-airway cough syndrome
123271862 12327186 Ventricular extrasystoles
123271862 12327186 Visual acuity reduced
123271862 12327186 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found